Evidence map›Paper›PMID 34178721›Full record

ArticleFrontiers in cellular and infection microbiology2021

A Novel Strategy to Coat Dopamine-Functionalized Titanium Surfaces With Agarose-Based Hydrogels for the Controlled Release of Gentamicin.

H Melis Soylu, Pascale Chevallier, Francesco Copes, Federica Ponti, Gabriele Candiani, Fatma Yurt, Diego Mantovani

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. [Progress in antibacterial/osteogenesis dual-functional surface modification strategy of titanium-based implants].Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery · 2023
    Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

H Melis SoyluDepartment Biomedical Technologies, The Institute of Natural and Applied Sciences, Ege University, Bornova, Turkey.
Pascale ChevallierLaboratory for Biomaterials and Bioengineering, Canada Research Chair Tier 1, Department of Min-Met-Materials Eng., University Hospital Research Center, Regenerative Medicine, Laval University, Quebec City, QB, Canada.
Francesco CopesLaboratory for Biomaterials and Bioengineering, Canada Research Chair Tier 1, Department of Min-Met-Materials Eng., University Hospital Research Center, Regenerative Medicine, Laval University, Quebec City, QB, Canada.
Federica PontiLaboratory for Biomaterials and Bioengineering, Canada Research Chair Tier 1, Department of Min-Met-Materials Eng., University Hospital Research Center, Regenerative Medicine, Laval University, Quebec City, QB, Canada.
Gabriele CandianiGenT LΛB and µBioMI LΛB, Department of Chemistry, Materials and Chemical Engineering "G. Natta", Politecnico di Milano, Milan, Italy.
Fatma YurtDepartment Biomedical Technologies, The Institute of Natural and Applied Sciences, Ege University, Bornova, Turkey.
Diego MantovaniLaboratory for Biomaterials and Bioengineering, Canada Research Chair Tier 1, Department of Min-Met-Materials Eng., University Hospital Research Center, Regenerative Medicine, Laval University, Quebec City, QB, Canada.
Université Laval · CAEge University · TRPolitecnico di Milano · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The use of spinal implants for the treatment of back disorders is largely affected by the insurgence of infections at the implantation site. Antibacterial coatings have been proposed as a viable solution to limit such infections. However, despite being effective at short-term, conventional coatings lack the ability to prevent infections at medium and long-term. Hydrogel-based drug delivery systems may represent a solution controlling the release of the loaded antibacterial agents while improving cell integration. Agarose, in particular, is a biocompatible natural polysaccharide known to improve cell growth and already used in drug delivery system formulations. In this study, an agarose hydrogel-based coating has been developed for the controlled release of gentamicin (GS). Methods: Sand blasted Ti6Al4V discs were grafted with dopamine (DOPA) solution. After, GS loaded agarose hydrogels have been produced and additioned with tannic acid (TA) and calcium chloride (CaCl Results: A homogeneous coating was obtained with all the hydrogel formulations. Moreover, the coatings presented a hydrophilic behavior and micro-scale surface roughness. The addition of TA in the hydrogel formulations showed an increase in the release time compared to the normal GS-agarose hydrogels. Moreover, the GS released from these gels was able to significantly inhibit Conclusions: Due to their surface properties, low cytotoxicity and high antibacterial effects, the hereby proposed gentamicin-loaded agarose-hydrogels provide new insight, and represent a promising approach for the surface modification of spinal implants, greatly impacting their application in the orthopedic surgical scenario.

Indexed as

GentamicinsTitaniumAnti-Bacterial AgentsCoated Materials, BiocompatibleDelayed-Action PreparationsDopamineHumansHydrogelsSepharoseStaphylococcus aureusAnti-Bacterial AgentsCoated Materials, BiocompatibleDelayed-Action PreparationsDopamineGentamicinsHydrogelsSepharoseTitaniumagaroseantibacterial coatingsgentamicinspinal implantsTi6Al4V

Identifiers

PMID34178721
PMCPMC8224171
OpenAlexW3169352465

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.